Your browser doesn't support javascript.
loading
Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension - 2021 NHLBI Workshop Report.
Gumz, Michelle L; Shimbo, Daichi; Abdalla, Marwah; Balijepalli, Ravi C; Benedict, Christian; Chen, Yabing; Earnest, David J; Gamble, Karen L; Garrison, Scott R; Gong, Ming C; Hogenesch, John B; Hong, Yuling; Ivy, Jessica R; Joe, Bina; Laposky, Aaron D; Liang, Mingyu; MacLaughlin, Eric J; Martino, Tami A; Pollock, David M; Redline, Susan; Rogers, Amy; Dan Rudic, R; Schernhammer, Eva S; Stergiou, George S; St-Onge, Marie-Pierre; Wang, Xiaoling; Wright, Jacqueline; Oh, Young S.
Afiliação
  • Gumz ML; Department of Physiology and Aging; Center for Integrative Cardiovascular and Metabolic Disease, Department of Medicine, Division of Nephrology, Hypertension and Renal Transplantation, University of Florida, Gainesville, FL (M.L.G.).
  • Shimbo D; Department of Medicine, The Columbia Hypertension Center, Columbia University Irving Medical Center, New York, NY (D.S.).
  • Abdalla M; Department of Medicine, Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center, New York, NY (M.A.).
  • Balijepalli RC; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD (R.C.B., Y.H., J.W., Y.S.O.).
  • Benedict C; Department of Pharmaceutical Biosciences, Molecular Neuropharmacology, Uppsala University, Sweden (C.B.).
  • Chen Y; Department of Pathology, University of Alabama at Birmingham, and Research Department, Birmingham VA Medical Center, AL (Y.C.).
  • Earnest DJ; Department of Neuroscience & Experimental Therapeutics, Texas A&M University, Bryan, TX (D.J.E.).
  • Gamble KL; Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, AL (K.L.G.).
  • Garrison SR; Department of Family Medicine, University of Alberta, Canada (S.R.G.).
  • Gong MC; Department of Physiology, University of Kentucky, Lexington, KY (M.C.G.).
  • Hogenesch JB; Department of Pediatrics, University of Cincinnati, OH (J.B.H.).
  • Hong Y; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD (R.C.B., Y.H., J.W., Y.S.O.).
  • Ivy JR; University/British Heart Foundation Centre for Cardiovascular Science, The Queen's Medical Research Institute, The University of Edinburgh, United Kingdom (J.R.I.).
  • Joe B; Department of Physiology and Pharmacology and Center for Hypertension and Precision Medicine, University of Toledo College of Medicine and Life Sciences, OH (B.J.).
  • Laposky AD; National Center on Sleep Disorders Research, Division of Lung Diseases, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD (A.D.L.).
  • Liang M; Center of Systems Molecular Medicine, Department of Physiology, Medical College of Wisconsin, Milwaukee, WI (M.L.).
  • MacLaughlin EJ; Department of Pharmacy Practice, Texas Tech University Health Sciences Center, Amarillo, TX (E.J.M.).
  • Martino TA; Center for Cardiovascular Investigations, Department of Biomedical Sciences, University of Guelph, Ontario, Canada (T.A.M.).
  • Pollock DM; Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, AL (D.M.P.).
  • Redline S; Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.R.).
  • Rogers A; Division of Molecular and Clinical Medicine, University of Dundee, United Kingdom (A.R.).
  • Dan Rudic R; Department of Pharmacology and Toxicology, Augusta University, GA (R.D.R.).
  • Schernhammer ES; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (E.S.S.).
  • Stergiou GS; Hypertension Center, STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece (G.S.S.).
  • St-Onge MP; Division of General Medicine, Department of Medicine, Columbia University Irving Medical Center' New York, NY (M.-P.S.-O.).
  • Wang X; Georgia Prevention Institute, Department of Medicine, Augusta University, GA (X.W.).
  • Wright J; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD (R.C.B., Y.H., J.W., Y.S.O.).
  • Oh YS; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD (R.C.B., Y.H., J.W., Y.S.O.).
Hypertension ; 80(3): 503-522, 2023 03.
Article em En | MEDLINE | ID: mdl-36448463
ABSTRACT
Healthy individuals exhibit blood pressure variation over a 24-hour period with higher blood pressure during wakefulness and lower blood pressure during sleep. Loss or disruption of the blood pressure circadian rhythm has been linked to adverse health outcomes, for example, cardiovascular disease, dementia, and chronic kidney disease. However, the current diagnostic and therapeutic approaches lack sufficient attention to the circadian rhythmicity of blood pressure. Sleep patterns, hormone release, eating habits, digestion, body temperature, renal and cardiovascular function, and other important host functions as well as gut microbiota exhibit circadian rhythms, and influence circadian rhythms of blood pressure. Potential benefits of nonpharmacologic interventions such as meal timing, and pharmacologic chronotherapeutic interventions, such as the bedtime administration of antihypertensive medications, have recently been suggested in some studies. However, the mechanisms underlying circadian rhythm-mediated blood pressure regulation and the efficacy of chronotherapy in hypertension remain unclear. This review summarizes the results of the National Heart, Lung, and Blood Institute workshop convened on October 27 to 29, 2021 to assess knowledge gaps and research opportunities in the study of circadian rhythm of blood pressure and chronotherapy for hypertension.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: National Heart, Lung, and Blood Institute (U.S.) / Hipertensão Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: National Heart, Lung, and Blood Institute (U.S.) / Hipertensão Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article